Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series

Alzheimer disease (AD) is the most common cause of dementia worldwide. Its clinical manifestations include a progressive loss of memory and other cognitive domains, as well as brain atrophy. An elevated homocysteine level (>15 µmol/L), known as hyperhomocysteinemia, is also an attributing risk fa...

Full description

Bibliographic Details
Main Authors: Ram Prakash Sah, C. S. Vidya, Pratibha Pereira, Shubha Jayaram, Anshu Kumar Yadav, P. Sujatha
Format: Article
Language:English
Published: Korea Geriatrics Society 2024-03-01
Series:Annals of Geriatric Medicine and Research
Subjects:
Online Access:http://www.e-agmr.org/upload/pdf/agmr-23-0135.pdf
_version_ 1827304376718327808
author Ram Prakash Sah
C. S. Vidya
Pratibha Pereira
Shubha Jayaram
Anshu Kumar Yadav
P. Sujatha
author_facet Ram Prakash Sah
C. S. Vidya
Pratibha Pereira
Shubha Jayaram
Anshu Kumar Yadav
P. Sujatha
author_sort Ram Prakash Sah
collection DOAJ
description Alzheimer disease (AD) is the most common cause of dementia worldwide. Its clinical manifestations include a progressive loss of memory and other cognitive domains, as well as brain atrophy. An elevated homocysteine level (>15 µmol/L), known as hyperhomocysteinemia, is also an attributing risk factor for AD, vascular pathologies, and brain atrophy. Neuroimaging studies including T2-weighted magnetic resonance imaging scans revealed white matter hyperintensities in the periventricular and deep white matter, enlarged ventricles, widened sulci, and decreased white matter mass, which are features of aging, as well as cerebrovascular changes. This case series investigated changes in biochemical marker levels including serum homocysteine, folate, and vitamin B12, and the degree of atrophic variations in cortical-subcortical white matter in AD. The present study hypothesized that serum homocysteine levels might be used as a surrogate marker to screen for AD at an earlier stage.
first_indexed 2024-04-24T17:30:03Z
format Article
id doaj.art-07db3dff604c45fc97573b5101d3670c
institution Directory Open Access Journal
issn 2508-4798
2508-4909
language English
last_indexed 2024-04-24T17:30:03Z
publishDate 2024-03-01
publisher Korea Geriatrics Society
record_format Article
series Annals of Geriatric Medicine and Research
spelling doaj.art-07db3dff604c45fc97573b5101d3670c2024-03-28T06:32:19ZengKorea Geriatrics SocietyAnnals of Geriatric Medicine and Research2508-47982508-49092024-03-0128111612010.4235/agmr.23.01351104Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case SeriesRam Prakash Sah0C. S. Vidya1Pratibha Pereira2Shubha Jayaram3Anshu Kumar Yadav4P. Sujatha5 Department of Anatomy, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India Department of Anatomy, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India Department of Geriatric Medicine, JSS Hospital, JSS Academy of Higher Education and Research, Mysore, India Department of Biochemistry, Mysore Medical College and Research Institute, Mysore, India Department of Biochemistry and Medical Genetics, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, IndiaAlzheimer disease (AD) is the most common cause of dementia worldwide. Its clinical manifestations include a progressive loss of memory and other cognitive domains, as well as brain atrophy. An elevated homocysteine level (>15 µmol/L), known as hyperhomocysteinemia, is also an attributing risk factor for AD, vascular pathologies, and brain atrophy. Neuroimaging studies including T2-weighted magnetic resonance imaging scans revealed white matter hyperintensities in the periventricular and deep white matter, enlarged ventricles, widened sulci, and decreased white matter mass, which are features of aging, as well as cerebrovascular changes. This case series investigated changes in biochemical marker levels including serum homocysteine, folate, and vitamin B12, and the degree of atrophic variations in cortical-subcortical white matter in AD. The present study hypothesized that serum homocysteine levels might be used as a surrogate marker to screen for AD at an earlier stage.http://www.e-agmr.org/upload/pdf/agmr-23-0135.pdfalzheimer's diseasebrain atrophyhomocysteinevitamin b12
spellingShingle Ram Prakash Sah
C. S. Vidya
Pratibha Pereira
Shubha Jayaram
Anshu Kumar Yadav
P. Sujatha
Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
Annals of Geriatric Medicine and Research
alzheimer's disease
brain atrophy
homocysteine
vitamin b12
title Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
title_full Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
title_fullStr Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
title_full_unstemmed Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
title_short Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
title_sort elevated homocysteine level and brain atrophy changes as markers to screen the alzheimer disease case series
topic alzheimer's disease
brain atrophy
homocysteine
vitamin b12
url http://www.e-agmr.org/upload/pdf/agmr-23-0135.pdf
work_keys_str_mv AT ramprakashsah elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries
AT csvidya elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries
AT pratibhapereira elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries
AT shubhajayaram elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries
AT anshukumaryadav elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries
AT psujatha elevatedhomocysteinelevelandbrainatrophychangesasmarkerstoscreenthealzheimerdiseasecaseseries